Glenmark, Biocon, Aurobindo slip 3% on Trump's generic drug tariff plan

Business Standard 1 h India

Nifty Pharma: The US President Donald Trump announced a proposal to impose phased tariff (up to 200%) regime on imported generic medicines aimed at encouraging pharmaceutical manufacturing within the United States.

Aggregated from the leading newsrooms of the country. Every story links to its original source.